PMC:7696151 / 85169-85497
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2534 | 12-20 | Species | denotes | patients | Tax:9606 |
| 2547 | 121-133 | Chemical | denotes | temsirolimus | MESH:C401859 |
| 2548 | 155-158 | Chemical | denotes | HCQ | MESH:D006886 |
| 2549 | 265-268 | Chemical | denotes | HCQ | MESH:D006886 |
| 2567 | 32-38 | Disease | denotes | tumors | MESH:D009369 |
| 2568 | 53-61 | Disease | denotes | melanoma | MESH:D008545 |
| 2569 | 207-212 | Disease | denotes | tumor | MESH:D009369 |
| 2570 | 309-317 | Disease | denotes | toxicity | MESH:D064420 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T210 | 53-61 | Phenotype | denotes | melanoma | http://purl.obolibrary.org/obo/HP_0002861 |
| T211 | 207-212 | Phenotype | denotes | tumor | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T542 | 73-226 | Sentence | denotes | In both cases, the standard intravenous dose of temsirolimus with 1200 mg of oral HCQ was considered safe and tolerated and inhibited tumor growth [167]. |